Related Experiment Video

Updated: May 30, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma

Zhiqin Li1, Hongyan Zhang, Jianping Yang

  • 1Department of Infection, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, Peoples Republic of China.

Cell Biology International
|August 26, 2011
PubMed

Insights

Aberrant DNA methylation silences key tumor suppressor genes in hepatocellular carcinoma (HCC). Promoter hypermethylation of RASSF1A, CHFR, GSTP1, and MGMT is frequent in HCC and linked to patient age and disease progression.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Aberrant promoter CpG island methylation is a key mechanism for tumor-related gene inactivation in human cancers.
  • Hepatocellular carcinoma (HCC) progression involves gene silencing, making epigenetic alterations a critical area of study.

Purpose of the Study:

  • To investigate the promoter methylation status of five DNA damage response genes in HCC tissues and cell lines.
  • To explore the correlation between methylation patterns and clinical features of HCC.
  • To assess the impact of DNA methylation on gene expression and its potential as a prognostic marker.

Main Methods:

  • Methylation-specific PCR (MSP) was used to examine the promoter methylation status of RASSF1A, CHFR, GSTP1, MGMT, and hMLH1 in 70 HCC tissues and five HCC cell lines.
  • Reverse transcription-PCR (RT-PCR) was employed to measure the mRNA expression levels of these genes.
  • The effect of 5-aza-20-deoxycytidine (5-Aza-dC) on gene expression was evaluated in treated cell lines.

Main Results:

  • High methylation frequencies were observed for RASSF1A (78%), CHFR (43%), GSTP1 (38%), and MGMT (32%) in HCC tissues. No hypermethylation of hMLH1 was detected.
  • Promoter hypermethylation of RASSF1A, CHFR, and GSTP1 was confirmed in HepG2 and SNU398 cells, while MGMT hypermethylation was found in Huh7 cells.
  • Treatment with 5-Aza-dC restored or increased gene expression, confirming aberrant DNA methylation's role in transcriptional silencing. RASSF1A hypermethylation correlated with patient age, and CHFR methylation correlated with HCC progression.

Conclusions:

  • Aberrant DNA methylation of RASSF1A, CHFR, GSTP1, and MGMT plays a significant role in the pathogenesis of HCC.
  • These epigenetic alterations may serve as important prognostic indicators for HCC patients.
  • Targeting these epigenetic changes could offer novel therapeutic strategies for hepatocellular carcinoma.

More Related Videos

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images09:42

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images

Published on: September 7, 2017

Methyl-binding DNA capture Sequencing for Patient Tissues08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...